Asthma is one of the most common chronic diseases in modern society and there is increasing evidence to suggest that its incidence and severity are increasing. There is a high prevalence of usage of complementary medicine for asthma. Current estimates suggest that 300 million people worldwide suffer from Bronchial asthma. This disease is very well recognized since ancient times in Unani system of medicine. Various ancient Unani Scholars and Physicians have use different Arabic terms like Rabu (short inspiration and prolonged expiration), Buhar, Dama, Intesab-un-Nafas and Zeequn Nafas under the caption of bronchial asthma. They also described the etiopathological factors, clinical features, types, and various complications of bronchial asthma that are presented in detail in their concerning treatises. Unani physicians have been treating this disease for thousands of years and they have mentioned various single as well as compound drugs viz; Kakra Seenghi (Pistacia integerrima) Arusa (Adhatoda vasica), Ajmod (Apium graveolens), Aslussoos (Glycyrrhiza glabra), Bazrul banj (Hyoscyamus niger), Biskhapra (Trianthema portulaca), Doodhi (Euphorbia hirta), Nil(Indigofera: tinctoria), Qinnab (Cannabis sativam) etc. and the compound formulations in the forms of -Kushta,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.